Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | 1.95% | 42.96 | 0.9% | $1172.19m | |
| LLY | Eli Lilly and Company | 1.04% | 124.00 | 1.0% | $1160.63m | |
| JNJ | Johnson & Johnson | 0.86% | 136.59 | 0.6% | $960.96m | |
| MRK | Merck & Co., Inc. | 1.12% | 80.72 | 0.6% | $933.10m | |
| BMY | Bristol-Myers Squibb Company | 1.70% | 50.98 | 1.4% | $779.97m | |
| ABBV | AbbVie, Inc. | 1.60% | 80.01 | 2.2% | $667.49m | |
| AZN | AstraZeneca PLC Sponsored ADR | 1.27% | 40.95 | 1.3% | $191.16m | |
| NVS | Novartis AG Sponsored ADR | 0.30% | 90.78 | 0.2% | $183.03m | |
| GSK | GlaxoSmithKline plc Sponsored ADR | 0.03% | 40.55 | 0.2% | $135.60m | |
| NVO | Novo Nordisk A/S Sponsored ADR Class B | 0.28% | 49.80 | 0.1% | $67.28m | |
| SNY | Sanofi Sponsored ADR | -0.36% | 41.18 | 0.2% | $36.78m | |
| LCI | Lannett Company, Inc. | 0.64% | 9.41 | 36.7% | $16.84m | |
| AKTX | Akari Therapeutics Plc Sponsored ADR | -2.70% | 1.80 | 1.7% | $0.06m | |
| EPIX | ESSA Pharma Inc | 1.96% | 3.64 | 0.1% | $0.04m |
Company Profile
Nightstar Therapeutics PLC is a clinical-stage gene therapy company, which engages in the development and commercialization of novel one-time treatments for patients suffering from rare inherited retinal diseases. Its pipeline includes NSR-REP1, for the treatment of choroideremia; NSR-RPGR, for the treatment of X-linked retinitis pigmentosa; and NSR-BEST1, for the treatment of vitelliform macular dystrophy. The company was founded by Robert MacLaren on July 6, 2017 and is headquartered in London, the United Kingdom.